Rep. Kevin Hern Unloads Shares of STERIS plc (NYSE:STE)

Key Points

• Rep. Kevin Hern sold $15,001–$50,000 of STERIS shares on September 15, 2026, from his traditional IRA, alongside sales of several other publicly traded companies.
• STERIS recently reported quarterly EPS of $2.59, beating estimates by $0.10, while revenue rose 7.3% year over year to $1.49 billion. The company issued fiscal 2027 EPS guidance of $11.00–$11.30.
• STERIS increased its quarterly dividend to $0.69 per share, equivalent to a 1.3% yield, and analysts maintained a generally positive outlook with a “Moderate Buy” consensus and a $271.33 average price target.

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of STERIS plc NYSE: STE. In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in STERIS stock on September 15th. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of CenterPoint Energy NYSE: CNP on 9/15/2026.
• Sold $1,001 - $15,000 in shares of TJX Companies NYSE: TJX on 9/15/2026.
• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 9/15/2026.
• Sold $15,001 - $50,000 in shares of NextEra Energy NYSE: NEE on 9/14/2026.
• Sold $1,001 - $15,000 in shares of Marsh & McLennan Companies NYSE: MRSH on 9/14/2026.
• Sold $15,001 - $50,000 in shares of IQVIA NYSE: IQV on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Home Depot NYSE: HD on 9/14/2026.
• Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Emerson Electric NYSE: EMR on 9/14/2026.
• Sold $15,001 - $50,000 in shares of Devon Energy NYSE: DVN on 9/14/2026.

STERIS Trading Up 1.0%

Shares of STE stock opened at $211.02 on Tuesday. The business's fifty day moving average price is $224.38 and its 200 day moving average price is $218.45. STERIS plc has a 1-year low of $195.14 and a 1-year high of $269.44. The firm has a market capitalization of $20.57 billion, a PE ratio of 25.80 and a beta of 0.91. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.91 and a quick ratio of 1.35.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 EPS for the quarter, topping the consensus estimate of $2.49 by $0.10. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The business's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm earned $2.34 EPS. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. As a group, sell-side analysts forecast that STERIS plc will post 11.12 EPS for the current fiscal year.

STERIS Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Friday, September 4th were paid a $0.69 dividend. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.3%. This is a boost from STERIS's previous quarterly dividend of $0.63. The ex-dividend date was Friday, September 4th. STERIS's dividend payout ratio (DPR) is presently 33.74%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on STE shares. Wall Street Zen raised shares of STERIS from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Piper Sandler reaffirmed an "overweight" rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a research report on Friday, August 7th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of STERIS in a research note on Monday, August 24th. Finally, UBS Group decreased their price target on shares of STERIS from $275.00 to $270.00 and set a "buy" rating on the stock in a report on Friday, August 7th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, STERIS has an average rating of "Moderate Buy" and a consensus price target of $271.33.

Insiders Place Their Bets

In related news, Director Mohsen Sohi sold 4,058 shares of the business's stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total value of $956,795.24. Following the completion of the sale, the director directly owned 24,305 shares of the company's stock, valued at $5,730,632.90. The trade was a 14.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.12% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On STERIS

Several hedge funds and other institutional investors have recently bought and sold shares of STE. Sequoia Financial Advisors LLC boosted its holdings in STERIS by 8.3% in the second quarter. Sequoia Financial Advisors LLC now owns 30,305 shares of the medical equipment provider's stock valued at $6,381,000 after purchasing an additional 2,324 shares during the last quarter. Engineers Gate Manager LP bought a new stake in shares of STERIS in the 2nd quarter worth about $2,000,000. NewEdge Advisors LLC raised its stake in shares of STERIS by 0.7% in the 2nd quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider's stock valued at $1,710,000 after purchasing an additional 56 shares in the last quarter. Squarepoint Ops LLC raised its stake in shares of STERIS by 1,373.7% in the 2nd quarter. Squarepoint Ops LLC now owns 41,898 shares of the medical equipment provider's stock valued at $8,822,000 after purchasing an additional 39,055 shares in the last quarter. Finally, Allworth Financial LP grew its stake in STERIS by 7.7% in the second quarter. Allworth Financial LP now owns 1,843 shares of the medical equipment provider's stock worth $388,000 after purchasing an additional 132 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma's 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027. Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma's 1st Congressional District. He declared candidacy for the 2026 election. Kevin Hern went into business as a McDonald's franchisee in 1999. He acquired 10 McDonald's franchises by 2012. He served on the McDonald's National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

STERIS Company Profile

STERIS plc NYSE: STE is a global provider of products and services designed to support infection prevention, sterilization, surgical procedures and other critical healthcare and life sciences activities. The company serves hospitals, ambulatory surgery centers, dental practices, pharmaceutical and biotechnology manufacturers, medical device companies, and research organizations.

Its offerings include sterilizers, washers, surgical tables and lights, operating-room equipment, endoscopy products, infection-prevention consumables, and related maintenance and technical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.